pcnindiaglobal
October 8, 2026October 12, 2026
CDSCO, Compliance Guides, Import Compliance, Medical Devices

CDSCO Licence for Blood Glucose Test Strips in India: Class C IVD Registration and Process

Blood glucose test strips are the consumable at the heart of self-monitoring for millions of people with diabetes in India, and a wrong reading can lead directly to a wrong insulin dose. Because a self-testing glucose result drives treatment of a chronic condition, CDSCO regulates the test strip as a Class C in-vitro diagnostic (IVD) — one of the higher IVD tiers — with the dedicated ISO 15197 performance standard and a performance-evaluation report behind the licence. This guide covers the full CDSCO registration pathway for blood glucose (glucometer) test strips under the Medical Devices Rules, 2017 — classification, licence route, ISO 15197, the documents, the fees and the timeline. This guide explains CDSCO registration for blood glucose test strips in India — risk class, licence forms, standards, documents, fees and timeline.

Is a CDSCO Registration Mandatory for Glucometer Test Strips?

Yes. Blood glucose test strips are a notified in-vitro diagnostic and cannot be manufactured, imported or sold in India without a CDSCO licence. IVDs follow the same MDR 2017 forms as other devices: because self-testing glucose strips are Class C, a domestic manufacturer applies to the Central Licensing Authority in Form MD-7 for a Form MD-9 licence, and an importer applies in Form MD-14 for a Form MD-15 import licence. The meter and the strips are matched as a system.

Risk Classification of Glucometer Test Strips

Every medical device in India falls into one of four risk classes (A, B, C, D) under the First Schedule of the Medical Devices Rules, 2017. The class fixes the authority, the form, the fee, the audit route and the timeline.

Glucometer Test Strips are classified as Class C (moderate-to-high risk). An IVD for self-testing that measures blood glucose to manage a chronic condition, where an incorrect result poses a significant risk to the patient, is classified at Class C under the IVD classification rules. Where a device could fall in two classes the higher class applies, and an accessory is classified in its own right. Always confirm against the current CDSCO classification list.

Which CDSCO Licence You Need for Glucometer Test Strips

To manufacture glucometer test strips in India (Class C) — apply in Form MD-7 to the Central Licensing Authority (CDSCO headquarters). The licensing authority grants the licence in Form MD-9. A CDSCO joint audit team inspects the manufacturing site before the licensing authority grants the licence — site inspection is mandatory for Class C and D.
To import glucometer test strips (any class) — the overseas manufacturer appoints an Indian Authorised Agent who files Form MD-14 with the Central Licensing Authority; CDSCO grants the import licence in Form MD-15.
Test licence — for a small quantity imported or made for testing, evaluation, demonstration or clinical investigation: Form MD-12 application, Form MD-13 licence.
Loan licence — using another licensee’s approved premises: Form MD-4 (Class A/B) or Form MD-8 (Class C/D) for a licence in Form MD-6 or MD-10.

Applicable Standards for Glucometer Test Strips

Blood glucose test strips are evaluated against the dedicated self-testing IVD standard plus IVD quality requirements:

ISO 15197 — in-vitro diagnostic test systems: requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus (system accuracy and user performance).
Performance Evaluation Report (PER) — analytical and clinical performance, precision, linearity, interference and haematocrit effects.
ISO 13485 — quality management system for the IVD manufacturer.
ISO 23640 — stability evaluation of IVD reagents (strip shelf-life).
ISO 14971 — risk management, including incorrect-result scenarios.
ISO 18113 — IVD labelling and information supplied by the manufacturer.

Documents Required for CDSCO Registration of Blood Glucose Test Strips

Whether you file for a manufacturing or an import licence, CDSCO expects the same core technical dossier built around the device:

Covering letter and application form — Form MD-3 / MD-7 (manufacture) or Form MD-14 (import) on the CDSCO Medical Device Online portal, stating every device, variant and site.
Device Master File (DMF) — device description and intended use, materials, design and manufacturing information, ISO 14971 risk file, verification/validation data, sterilisation validation where applicable, shelf-life/stability data and the Essential Principles checklist.
Plant Master File (PMF) — site layout, equipment, utilities/HVAC, organisation chart with competent technical staff and the QMS procedures governing production.
ISO 13485 QMS certificate — current, with a scope covering the device.
Essential Principles of Safety and Performance — a completed checklist mapping the device against each applicable principle with the standard/evidence relied on.
Risk management file (ISO 14971) — hazards, risk controls and residual-risk justification.
Test / performance reports — against the applicable BIS/IS or ISO/IEC standards from an accredited laboratory.
Labels, IFU and packaging — meeting the labelling requirements of the Medical Devices Rules (manufacturer, licence number, sterile status, single-use symbols).
Undertaking and declaration of conformity to the Essential Principles and applicable standards.
Government fee receipt — paid online through the CDSCO portal.

Device-Specific Documents for Blood Glucose Test Strips

Device-specific documents on top of the core set for glucometer test strips:

ISO 15197 system-accuracy and user-performance study for the meter-and-strip system.
Performance Evaluation Report — precision, linearity, interference (e.g. maltose, ascorbate) and haematocrit range.
Stability (ISO 23640) data — open- and closed-vial strip shelf-life and transport stability.
Traceability of calibration to a reference measurement procedure.
Meter compatibility evidence tying the strips to the specific glucometer(s).
Country-of-origin approval / Free Sale Certificate for imports.

For an import licence (Form MD-14) there are three further essentials:

Free Sale Certificate (FSC) — from the National Regulatory Authority of the country of origin, legalised (apostille/embassy attestation).
Country-of-origin regulatory approval — US FDA 510(k)/PMA, EU CE certificate or equivalent.
Power of Attorney and Authorised Agent licence — notarised, legalised PoA to the Indian Authorised Agent, plus the agent’s valid wholesale/manufacturing licence.

QMS & Essential Principles — What CDSCO Checks

Essential Principles of Safety and Performance (Fifth Schedule) — the device must be safe and perform as intended, with risks reduced as far as possible. Shown through recognised standards and the risk-management file.
Quality Management System (ISO 13485) — design controls, supplier control, process validation, traceability, complaint handling and CAPA, evidenced at audit.
Risk management (ISO 14971) — a living file with residual risks justified and communicated in the IFU.
Clinical evidence — proportionate to the class: clinical evaluation for lower-risk devices and clinical investigation data for many Class C/D and novel devices.

Label & IFU Requirements Specific to Glucometer Test Strips

IVD labelling is governed by ISO 18113 and is checked closely for lot, calibration and expiry information:

Product name, IVD symbol, and “for self-testing” where applicable.
Manufacturer name and address, and the CDSCO licence number.
Lot/batch number, calibration code, date of manufacture and expiry date.
Storage conditions and open-vial stability.
Compatible meter(s) and the measurement units, with the IFU and quick-reference guide.

Why Glucose Strips Sit Higher Than Many IVDs

Not all IVDs are the same class, and glucose test strips are a good example of why the intended use matters more than the product looking simple. A qualitative test that only screens is often Class B, but a quantitative self-testing device whose result directly guides insulin dosing for a chronic condition carries a real risk if it is wrong — so CDSCO places self-testing glucose monitoring at Class C. Confirm the exact IVD class against the current CDSCO IVD classification list before filing, because it decides whether you are on the MD-5 (State) or MD-9 (Central) manufacturing route.

Step-by-Step CDSCO Registration Process for Blood Glucose Test Strips

Confirm the classification. Fix the risk class against the CDSCO classification list and the First Schedule — Class C here — which decides the form, authority, fee and audit route.
Choose the route. Manufacture (Form MD-7 → MD-9) or import (Form MD-14 → MD-15). Importers appoint an Indian Authorised Agent holding a valid manufacturing or wholesale licence.
Build the Device Master File and Plant Master File. Assemble device description, materials, design and process data, the ISO 14971 risk file, sterilisation/stability data and the site file with the QMS.
Complete the Essential Principles checklist. Map the device against each applicable essential principle and cite the BIS/IS or ISO/IEC standard or test report relied on.
Draw the test and performance reports. Test to the applicable standards at an accredited laboratory. Sterile and measuring devices carry additional validation.
Register and file on the CDSCO Medical Device Online portal. Create the account, pay the government fee online and upload the full dossier under the correct form.
Site audit / inspection. A CDSCO joint audit team inspects the manufacturing site before the licensing authority grants the licence — site inspection is mandatory for Class C and D.
Respond to queries and receive the licence. Answer the deficiency letter within the stipulated period. On approval the licence issues in Form MD-9 (manufacture) or MD-15 (import).

CDSCO Registration Fees and Timeline for Blood Glucose Test Strips

The Second Schedule of the Medical Devices Rules sets the fees, and you pay them online through the CDSCO portal. For manufacture of a Class C device the fee is Rs 50,000 per site plus Rs 1,000 for each distinct device, paid to the Central Licensing Authority (CDSCO headquarters). CDSCO charges import fees under Form MD-15 per site and per device in USD — roughly USD 1,000 per site plus USD 50 per device for lower-risk devices, up to about USD 3,000 per site plus USD 1,500 per device for Class C and D. A test licence (Form MD-13) carries a modest fee. Always confirm the current figure on the CDSCO portal before filing.

A complete Class C manufacturing file typically clears in about six to nine months. An import (MD-15) file usually takes six to nine months. Every deficiency letter effectively restarts the clock. Unlike the old registration certificates, an MDR 2017 licence does not expire — it stays valid as long as you pay the retention fee (equal to the licence fee) every five years and meet the conditions of licence.

Common Mistakes That Trigger a CDSCO Query

Common query reasons for glucose-strip IVD applications are:

ISO 15197 accuracy study that does not meet the current edition’s limits, or is not a user-performance study.
Stability data that does not support the labelled open- and closed-vial shelf-life.
Strips registered without tying them to the specific meter(s).
IVD labelling missing lot, calibration code or the IVD symbol per ISO 18113.
Free Sale Certificate scope not covering the exact IVD on import.

Related Approvals to Plan Alongside CDSCO

DGFT Importer-Exporter Code — mandatory for any importer of record before the first consignment.
Wholesale / sale licence (Form 20B/21B or Form MD-42) — for stocking and distributing the device. The Indian Authorised Agent for an import licence must already hold one.
Legal Metrology (LMPC) registration — importers of pre-packaged devices declare MRP, net quantity, importer details and country of origin on the pack.
BIS certification — where the device or its electrical components fall under a mandatory BIS/CRS scheme.

Post-Approval Obligations

Print the licence number on the label and keep the Essential Principles conformity current.
Operate a Post-Market Surveillance (PMS) system and file the Periodic Safety Update Report (PSUR) on the schedule for the device’s class.
Report adverse events and field safety corrective actions through the Materiovigilance Programme of India (MvPI) and to CDSCO within the prescribed timelines.
Report any change in device, materials, site, labelling or QMS, and any regulatory action or recall in another country.
Retain distribution records for traceability and allow CDSCO to draw samples and inspect the premises.
Pay the retention fee every five years to keep the licence in force, and track BIS/ISO standard revisions.

FAQs on CDSCO Registration for Blood Glucose Test Strips

What CDSCO class are blood glucose test strips?

Self-testing blood glucose strips are a Class C IVD, so a domestic manufacturer files Form MD-7 for an MD-9 licence with the Central Licensing Authority, and an importer files Form MD-14 for an MD-15 licence. Confirm the class on the current CDSCO IVD list.

Which standard applies to glucose test strips?

ISO 15197 — the standard for blood-glucose monitoring systems for self-testing — is the key performance standard, supported by a performance-evaluation report and ISO 23640 stability data.

Are the meter and strips registered together?

The strips are registered as part of the meter-and-strip system, and the performance evidence must tie the strips to the specific glucometer(s) they are used with.

Do IVDs follow the same forms as other devices?

Yes — IVDs use the same MDR 2017 forms (MD-5/MD-9 for manufacture, MD-15 for import). The difference is the performance-evaluation evidence rather than a separate form set.

How long does glucose-strip registration take?

Budget roughly six to nine months for a complete Class C IVD manufacturing (MD-9) or import (MD-15) file with the ISO 15197 study and stability data.

Does the licence expire?

No — the MDR 2017 licence is perpetual, subject to the five-yearly retention fee and continued compliance.

Related CDSCO Registration Guides

Need end-to-end help? See our CDSCO registration services, or read these related guides:

Official references: Central Drugs Standard Control Organisation (CDSCO) and the CDSCO MD Online portal.

Why Choose PCN India Global

Classification triage — we confirm the correct risk class for your glucometer test strips against the current CDSCO list before we draft anything.
Route selection — manufacture (MD-5/MD-9) or import (MD-15), with the Indian Authorised Agent arrangement handled.
Dossier build — Device Master File, Plant Master File, Essential Principles checklist and ISO 13485/ISO 14971 readiness.
Standards and testing — the right BIS/IS or ISO/IEC standards mapped and accredited test reports coordinated.
End-to-end online filing — application, audit support, query response and the licence grant managed for you.
Adjacent approvals — DGFT/IEC, LMPC, wholesale/sale licence and BIS coordinated alongside your CDSCO licence.

PCN India Global manages the complete CDSCO process for glucometer test strips — from classification and route selection to Device and Plant Master File preparation, online filing, audit support and the licence grant. WhatsApp or call +91 80109 05029, or email admin@pcnindiaglobal.com, to get your registration underway.

Related Compliance Guides

CDSCO Licence for Coronary Stents
CDSCO Registration for Syringes
CDSCO Licence for Surgical Gloves
CDSCO Licence for Ventilators